This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Stryka-969

StrykaGen

Drug Names(s): Stryka969, Stryka 969

Description: Stryka-969 is a small molecule therapeutic that increases alpha7beta1 integrin in muscle cells. The company does not know the direct mechanism, but has a strong lead on it. However, they are not disclosing what they believe it is.


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug